Hinova Pharmaceuticals Inc. (SHA:688302)
China
· Delayed Price · Currency is CNY 42.03
-0.57 (-1.34%)
At close: Mar 9, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 4.16 billion as of March 9, 2026. Its market cap has increased by 34.58% in one year.
Market Cap
4.16B
Enterprise Value
3.35B
Revenue
20.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.03
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 4.16B, an increase of 39.63%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.16B | -14.52% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 4.20B |
| Zhejiang Shouxiangu Pharmaceutical | 4.15B |
| Beijing Scitop Bio-tech | 4.40B |
| Zhejiang Wecome Pharmaceutical Company | 4.02B |
| Baolingbao Biology | 4.02B |
| Qingdao Vland Biotech INC. | 3.94B |
| Boji Medical Technology | 3.89B |
| Shenzhen Bioeasy Biotechnology | 3.81B |